Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AZ5104 |
Synonyms | |
Therapy Description |
AZ5104 is the active metabolite of Osimertinib, which inhibits wild-type and mutant EGFR and ERBB2 (HER2), potentially resulting in decreased tumor growth (PMID: 27439477, PMID: 28274957, PMID: 31744223). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZ5104 | AZ-5104 | EGFR Inhibitor 3rd gen 26 | AZ5104 is the active metabolite of Osimertinib, which inhibits wild-type and mutant EGFR and ERBB2 (HER2), potentially resulting in decreased tumor growth (PMID: 27439477, PMID: 28274957, PMID: 31744223). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|